Adaptive cardiovascular hormones in a spectrum of heart failure phenotypes
- 1 June 2015
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 189, 6-11
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Utility of Biomarkers in the Differential Diagnosis of Heart Failure in Older People: Findings from the Heart Failure in Care Homes (HFinCH) Diagnostic Accuracy StudyPLOS ONE, 2013
- Aliskiren, ALTITUDE, and the Implications for ATMOSPHEREEuropean Journal of Heart Failure, 2012
- Influence of confounding factors on plasma Mid-Regional pro-Adrenomedullin and Mid-Regional pro-A-type Natriuretic Peptide concentrations in healthy individualsBiomarkers, 2011
- The Predictive Value of Stable Precursor Fragments of Vasoactive Peptides in Patients with Chronic Heart Failure: Data from the GISSI-Heart Failure (GISSI-HF) TrialEuropean Journal of Heart Failure, 2010
- Rationale and Design of the Karolinska-Rennes (KaRen) Prospective Study of Dyssynchrony in Heart Failure with Preserved Ejection FractionEuropean Journal of Heart Failure, 2009
- Impact of left ventricular assist device (LVAD) support on the cardiac reverse remodeling processProgress in Biophysics and Molecular Biology, 2008
- Atrial myocardium is the predominant inotropic target of adrenomedullin in the human heartAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Neurohumoral Pathways in Heart Failure With Preserved Systolic FunctionProgress in Cardiovascular Diseases, 2005
- Adrenomedullin (ADM) in the human forearm vascular bed: effect of neutral endopeptidase inhibition and comparison with proadrenomedullin NH2‐terminal 20 peptide (PAMP)British Journal of Clinical Pharmacology, 2001
- Transient reduction without normalization of brain natriuretic peptide early after heart transplantationThe Journal of Thoracic and Cardiovascular Surgery, 1998